INTERACTION DEPENDENT SECONDARY INFECTION SYSTEM (ISIS)

Information

  • Research Project
  • 2869451
  • ApplicationId
    2869451
  • Core Project Number
    R43GM059775
  • Full Project Number
    1R43GM059775-01
  • Serial Number
    59775
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/1999 - 26 years ago
  • Project End Date
    9/30/1999 - 25 years ago
  • Program Officer Name
  • Budget Start Date
    4/1/1999 - 26 years ago
  • Budget End Date
    9/30/1999 - 25 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/1/1999 - 26 years ago
Organizations

INTERACTION DEPENDENT SECONDARY INFECTION SYSTEM (ISIS)

The elucidation of cell signaling pathways and protein oligomerization mechanisms will lead to a better understanding of disease as well as cellular homeostasis. Since essentially all biochemical interactions involve protein ligand interactions, the development of efficient methods of detecting these interactions is critical. The novel phage display system proposed here will enable the detection of protein-protein interactions in solution in a single reaction. This will be an improvement over the current technology that often requires five to six rounds of enrichment and can be plagued by isolation of non-specific phage clones. The high efficiency that is predicted in this system will come about by interaction-dependent selective infection of bacteria by phage encoding the interactor. In this feasibility study, we will construct the reagents required to show that an infective phage can rescue the infectivity of a non-infective phage by means of a protein-protein interaction. This system will consist of a bait phage and prey phage. Upon a successful interaction, the prey phage will be able to infect F' E. coli. These two phage populations will be encoded by plasmids with separate antibiotic resistance markers. To retrieve positive binders, the infected bacteria will be selected on the antibiotic marker encoded by the prey phage. PROPOSED COMMERCIAL APPLICATIONS: Commercialization of the components of the system described here could lead to more efficient phage display systems for library screening. Conventional, single phage systems could be improved by utilizing the data presented as preliminary support of this concept. Full development of this system could lead to a new generation of more efficient phage display systems that would allow easier high throughput screening of libraries for protein- protein interactions.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
  • Organization Name
    INVITROGEN CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    CARLSBAD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    920087313
  • Organization District
    UNITED STATES